Error message

Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1442 of includes/bootstrap.inc).
Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1442 of includes/bootstrap.inc).
Deprecated function: Optional parameter $type declared before required parameter $nid is implicitly treated as a required parameter in include_once() (line 1442 of includes/bootstrap.inc).

T 0548/91 (Dipeptides/SCHERING) of 7.2.1994

European Case Law Identifier:

ECLI:EP:BA:1994:T054891.19940207

Date of decision:

07 February 1994

Case number:

T 0548/91

Application number:

IPC class:

Language of proceedings:

EN

Distribution:

Download and more information:

Decision text in EN (PDF, 1Â MB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in:	EN
Versions:	Unpublished

Title of application:

Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them

Applicant name:

Schering Corporation

Opponent name:

(01) ADIR
(02) Knappwost, Adolf, Professor Dr.
(03) Hoechst Aktiengesellschaft

Board:

3.3.02

Headnote:

-

Relevant legal provisions:

European Patent Convention 1973 Art 56
European Patent Convention 1973 Art 83
European Patent Convention 1973 Art 123

Keywords:

Admissability of appeals
Appellant (01) - adversely affected (no)
Appellant (02) - man of straw (no)
Sufficiency of disclosure (yes)
Added subject-matter - no (after amendment)
Inventive step (yes) - no reasons to question the advantages demonstrated

Catchwords:

-

Cited decisions:

G 0001/84
G 0009/91
T 0244/85
T 0383/88
T 0635/88
T 0182/89
T 0299/89
T 0012/90
T 0289/91
T 0409/91

Citing decisions:

T 0339/93
T 0798/93
T 0301/95
T 0052/96
T 0643/96
T 0462/98
T 0973/03
T 2402/10
T 2094/12
T 0735/13

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t910548eu1.html

Date retrieved: 17 May 2021

22 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

Case Law Book: I Patentability

X CLR I D 9.8.2 Structural similarity

Case Law Book: II Conditions to be met by an Application

X CLR II C 5.4 Invention to be performed over whole range claimed

X CLR II C 8.1 ‍‍Article 83 EPC and support from the description

X CLR II C 9 Evidence

Case Law Book: IV Divisional Applications

X CLR IV C 2.1.4 Filing of opposition on behalf of a third party – straw man

Case Law of the Enlarged Board

X G 0001/84 (Opposition by proprietor) of 24.7.1985

X G 0009/91 (Power to examine) of 31.3.1993

General Case Law

X T 0244/85 (Aluminium trihydroxide) of 23.1.1987

X T 0383/88 (Pyrimidinones/BIOMEASURE) of 1.12.1992

X T 0635/88 (Opponent-Identifiability) of 28.2.1992

X T 0182/89 (Extent of opposition) of 14.12.1989

X T 0299/89 () of 31.1.1991

X T 0012/90 () of 23.8.1990

X T 0289/91 (ACE inhibitors) of 10.3.1993

X T 0409/91 (Fuel oils) of 18.3.1993

X T 0339/93 (Modified vaccinia virus/HEALTH RESEARCH, INC.) of 18.4.1996

X T 0798/93 (Identification of real opponent) of 20.6.1996

X T 0301/95 (Straw man) of 27.6.1997

X T 0643/96 (Bioisosterism/BEECHAM) of 14.10.1996

X T 2402/10 (Prostaglandin derivatives / Pfizer) of 10.5.2012

X T 2094/12 () of 5.4.2017

X T 0735/13 () of 11.10.2017